Results 101 to 110 of about 1,627 (175)

Hyperthermia and radiotherapy: physiological basis for a synergistic effect. [PDF]

Front Oncol
Righini MF, Durham A, Tsoutsou PG.
europepmc   +1 more source

The value of PFS36 as a primary endpoint for radiotherapy trials in patients with LACC: individual patient data from the Chinese NCC and validation from 26 RCTs. [PDF]

J Natl Cancer Cent
Yang X, Zhang Y, Jia S, Yang Y, Zhu J, Li W, Wu L, An J, Huang M.   +8 more
europepmc   +1 more source

Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes. [PDF]

Br J Radiol, 2019
Wardman P.
europepmc   +1 more source

Non-[¹⁸F]FDG PET-Radiopharmaceuticals in Oncology. [PDF]

Pharmaceuticals (Basel)
Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C.   +2 more
europepmc   +1 more source

Use of Radiomics in Characterizing Tumor Hypoxia. [PDF]

Int J Mol Sci
Huang M, Law HKW, Tam SY.
europepmc   +1 more source

OXYGEN DEPENDENCE OF MISONIDAZOLE BINDING IN SPHEROIDS ASSESSED BY SIMULTANEOUS MICROELECTRODE MEASUREMENTS AND 3H-MISONIDAZOLE LABELING

, 1991
W. MUELLER-KLIESER, M.W. GROSS, U. KARBACH   +2 more
core   +1 more source

Immobilization of CuO onto melamine functionalized magnetic nanocomposite: an efficient catalyst for the Preparation of benzimidazole compounds. [PDF]

Sci Rep
Asdollahpour Z, Baharfar R, Asghari S.
europepmc   +1 more source

Importance and Involvement of Imidazole Structure in Current and Future Therapy. [PDF]

Molecules
Burlacu AP, Drăgan M, Oniga O, Matei MN, Oniga I, Lisă EL, Stefan CS, Dragostin OM.   +7 more
europepmc   +1 more source

Split dose cytotoxic experiments with misonidazole

, 1978
I J Stratford
core   +1 more source

Radiation Therapy Personalization in Cancer Treatment: Strategies and Perspectives. [PDF]

Int J Mol Sci
Calvaruso M, Pucci G, Alberghina C, Minafra L.   +3 more
europepmc   +1 more source